Therefore, intervening in diabetes patients with comorbid MS is highly significant in terms of delaying the progression of diabetes and the onset of coronary heart disease.
← all excerpts
The evaluation of cognitive-behavioral therapy-based intervention on type 2 diabetes patients with comorbid metabolic syndrome: a randomized controlled trial.
1
—
—